| Patent | Date |
|---|
RNAi probes targeting cancer-related proteins
Grant 9,487,777 - Gleave , et al. November 8, 2 | 2016-11-08 |
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
Grant 9,101,646 - Gleave , et al. August 11, 2 | 2015-08-11 |
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
Grant 9,095,602 - Gleave , et al. August 4, 2 | 2015-08-04 |
TRPM-2 antisense therapy
Grant 9,074,209 - Gleave , et al. July 7, 2 | 2015-07-07 |
Compositions and methods for treatment of prostate and other cancers
Grant 8,772,470 - Gleave , et al. July 8, 2 | 2014-07-08 |
RNAi probes targeting cancer-related proteins
Grant 8,759,308 - Gleave , et al. June 24, 2 | 2014-06-24 |
Trpm-2 Antisense Therapy
App 20140100261 - Gleave; Martin ; et al. | 2014-04-10 |
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
Grant 8,580,761 - Gleave , et al. November 12, 2 | 2013-11-12 |
TRPM-2 antisense therapy
Grant 8,536,149 - Gleave , et al. September 17, 2 | 2013-09-17 |
Chemo- And Radiation-sensitization Of Cancer By Antisense Trpm-2 Oligodeoxynucleotides
App 20130143944 - Gleave; Martin ; et al. | 2013-06-06 |
Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
App 20130096180 - Gleave; Martin ; et al. | 2013-04-18 |
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
Grant 8,389,491 - Gleave , et al. March 5, 2 | 2013-03-05 |
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
Grant 8,361,981 - Gleave , et al. January 29, 2 | 2013-01-29 |
Trpm-2 Antisense Therapy
App 20120322850 - Gleave; Martin ; et al. | 2012-12-20 |
RNAi Probes Targeting Cancer-Related Proteins
App 20120202873 - Gleave; Martin ; et al. | 2012-08-09 |
TRPM-2 antisense therapy
Grant 8,173,615 - Gleave , et al. May 8, 2 | 2012-05-08 |
Bispecific oligonucleotide for the treatment of CNS malignancies
Grant 8,168,610 - Gleave , et al. May 1, 2 | 2012-05-01 |
Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
App 20120077861 - Gleave; Martin ; et al. | 2012-03-29 |
Treatment of cancer by inhibition of IGFBP's and clusterin
Grant 7,973,017 - Gleave July 5, 2 | 2011-07-05 |
Treatment Of Cancer With A Combination Of An Agent That Perturbs The Egf Signaling Pathway And An Oligonucleotide That Reduces Clusterin Levels
App 20110142827 - Gleave; Martin ; et al. | 2011-06-16 |
TRPM-2 Antisense Therapy
App 20110021603 - GLEAVE; MARTIN ; et al. | 2011-01-27 |
RNAi Probes Targeting Cancer-Related Proteins
App 20110009472 - Gleave; Martin ; et al. | 2011-01-13 |
RNAi probes targeting cancer-related proteins
Grant 7,820,635 - Gleave , et al. October 26, 2 | 2010-10-26 |
Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
App 20100267808 - Gleave; Martin ; et al. | 2010-10-21 |
TRPM-2 antisense therapy
Grant 7,732,422 - Gleave , et al. June 8, 2 | 2010-06-08 |
Treatment of Cancer by Inhibition of HSP27
App 20090281166 - Gleave; Martin ; et al. | 2009-11-12 |
Chemo- and Radiation-sensitization of Cancer by Antisense TRPM-2 Oligodeoxynucleotides
App 20090258089 - Gleave; Martin ; et al. | 2009-10-15 |
TRPM-2 antisense therapy
Grant 7,592,323 - Gleave , et al. September 22, 2 | 2009-09-22 |
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
Grant 7,569,551 - Gleave , et al. August 4, 2 | 2009-08-04 |
Compositions and methods for treatment of prostate and other cancers
Grant 7,550,580 - Gleave , et al. June 23, 2 | 2009-06-23 |
TRPM-2 antisense therapy
Grant 7,534,773 - Gleave , et al. May 19, 2 | 2009-05-19 |
RNAi Probes Targeting Cancer-Related Proteins
App 20080274996 - Gleave; Martin ; et al. | 2008-11-06 |
TRPM-2 antisense therapy
Grant 7,368,436 - Gleave , et al. May 6, 2 | 2008-05-06 |
TRPM-2 Antisense Therapy
App 20080064651 - Gleave; Martin ; et al. | 2008-03-13 |
Antisense Therapy for Hormone-Regulated Tumors
App 20080051362 - Gleave; Martin ; et al. | 2008-02-28 |
Treatment of Cancer With a Combination of an Agent that Perturbs the EGF Signaling Pathway and an Oligonucleotide that Reduces Clusterin Levels
App 20080014198 - Gleave; Martin ; et al. | 2008-01-17 |
Antisense therapy for hormone-regulated tumors
Grant 7,297,684 - Gleave , et al. November 20, 2 | 2007-11-20 |
Treatment of melanoma by reduction in clusterin levels
Grant 7,285,541 - Gleave , et al. October 23, 2 | 2007-10-23 |
Antisense insulin-like growth factor binding protein (IGFBP)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy
Grant 7,196,067 - Gleave , et al. March 27, 2 | 2007-03-27 |
RNAi probes targeting cancer-related proteins
App 20060178329 - Gleave; Martin ; et al. | 2006-08-10 |
TRPM-2 antisense therapy using an oligonucleotide having 2'-O-(2-methoxy)ethyl modifications
Grant 6,900,187 - Gleave , et al. May 31, 2 | 2005-05-31 |
Method for treatment of angiogenic disorders
App 20040224914 - Jackson, John K. ; et al. | 2004-11-11 |
Method for treatment of cancerous angiogenic disorders
App 20040220131 - Jackson, John K. ; et al. | 2004-11-04 |
Compositions and Methods for Treatment of Prostate and Other Cancers
App 20040127441 - Gleave, Martin ; et al. | 2004-07-01 |
RNAi probes targeting cancer-related proteins
App 20040096882 - Gleave, Martin ; et al. | 2004-05-20 |
Treatment of melanoma by reduction in clusterin levels
App 20040082534 - Gleave, Martin ; et al. | 2004-04-29 |
Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy
App 20040072776 - Gleave, Martin ; et al. | 2004-04-15 |
TRPM-2 antisense therapy using an oligonucleotide having 2'-O-(2-methoxy)ethyl modifications
App 20030166591 - Gleave, Martin ; et al. | 2003-09-04 |
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
App 20030158130 - Gleave, Martin ; et al. | 2003-08-21 |
Bispecific antisense olignucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
App 20030158143 - Gleave, Martin ; et al. | 2003-08-21 |
TRPM-2 antisense therapy
App 20020128220 - Gleave, Martin | 2002-09-12 |
| 